Results from the tranexamic acid for primary intracerebral haemorrhage-2 (TICH-2) trial

Background: Haematoma expansion leads to worse outcome in intracerebral haemorrhage (ICH). Tranexamic acid (TXA) is a promising haemostatic agent to prevent haematoma expansion and improve outcome after ICH. Methods: TICH-2 is a multicentre prospective double blind randomised controlled trial, whic...

Full description

Bibliographic Details
Main Authors: Sprigg, Nikola, Flaherty, Katie, Law, Zhe Kang, Appleton, Jason P., Scutt, Polly, Krishnan, Kailash, Bath, Philip M.
Format: Conference or Workshop Item
Published: 2018
Online Access:https://eprints.nottingham.ac.uk/51139/

Similar Items